The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor.

PubWeight™: 2.18‹?› | Rank: Top 2%

🔗 View Article (PMC 4335600)

Published in Int J Stroke on December 10, 2014

Authors

Priya Parmar1, Rita Krishnamurthi, M Arfan Ikram, Albert Hofman, Saira S Mirza, Yury Varakin, Michael Kravchenko, Michael Piradov, Amanda G Thrift, Bo Norrving, Wenzhi Wang, Dipes Kumar Mandal, Suzanne Barker-Collo, Ramesh Sahathevan, Stephen Davis, Gustavo Saposnik, Miia Kivipelto, Shireen Sindi, Natan M Bornstein, Maurice Giroud, Yannick Béjot, Michael Brainin, Richie Poulton, K M Venkat Narayan, Manuel Correia, António Freire, Yoshihiro Kokubo, David Wiebers, George Mensah, Nasser F BinDhim, P Alan Barber, Jeyaraj Durai Pandian, Graeme J Hankey, Man Mohan Mehndiratta, Shobhana Azhagammal, Norlinah Mohd Ibrahim, Max Abbott, Elaine Rush, Patria Hume, Tasleem Hussein, Rohit Bhattacharjee, Mitali Purohit, Valery L Feigin, Stroke RiskometerTM Collaboration Writing Group

Author Affiliations

1: AUT University, NZ.

Associated clinical trials:

Polipill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE) (PROMOTE) | NCT05155137

Articles cited by this

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet (2011) 19.21

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J (2012) 13.74

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25

Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) (1981) 11.00

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke (2010) 10.66

Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06

Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ (1976) 7.43

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J (2007) 5.92

Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol (2010) 5.79

Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88

Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J (2007) 4.88

Quantification of the completeness of follow-up. Lancet (2002) 4.77

Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ (2003) 4.74

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ (2010) 4.46

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35

Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst (2011) 2.61

The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol (2013) 2.56

Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc (1996) 2.32

Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation (2010) 2.25

Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative. Circulation (2012) 2.17

Alcohol consumption and risk for stroke among Chinese men. Ann Neurol (2007) 1.79

Familial history of stroke and stroke risk. The Family Heart Study. Stroke (1997) 1.61

Stroke knowledge and awareness: an integrative review of the evidence. Age Ageing (2009) 1.49

Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. BMJ (2013) 1.33

Patients with traumatic brain injury: population-based study suggests increased risk of stroke. Stroke (2011) 1.31

Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil (2009) 1.28

Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis (2014) 1.28

Stroke awareness in the general population: knowledge of stroke risk factors and warning signs in older adults. BMC Geriatr (2009) 1.21

Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study. BMC Public Health (2010) 1.16

Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM Project. Stroke (2009) 1.08

Modifiable etiological factors and the burden of stroke from the Rotterdam study: a population-based cohort study. PLoS Med (2014) 1.05

Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992. J Clin Epidemiol (2001) 1.05

Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis (2009) 0.99

Prevalence of cardiovascular disease risk amongst the population eligible for the NHS Health Check Programme. Eur J Prev Cardiol (2011) 0.97

Assessing risk prediction models using individual participant data from multiple studies. Am J Epidemiol (2013) 0.95

The relation of alcohol consumption to cardiovascular risk factors and stroke. The west Birmingham stroke project. J Neurol Neurosurg Psychiatry (1993) 0.95

Feasibility, reliability, and validity of a smartphone based application for the assessment of cognitive function in the elderly. PLoS One (2013) 0.94

A new paradigm for primary prevention strategy in people with elevated risk of stroke. Int J Stroke (2014) 0.86

External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study. Prev Med (2013) 0.85

Framingham stroke risk function in a large population-based cohort of elderly people: the 3C study. Stroke (2009) 0.83

Family history as a risk factor for early-onset stroke/transient ischemic attack among adults in the United States. Public Health Genomics (2009) 0.82

Assessing the performance of the Framingham Stroke Risk Score in the reasons for geographic and racial differences in stroke cohort. Stroke (2014) 0.81

Methodology of a population-based stroke and TIA incidence and outcomes study: the Auckland Regional Community Stroke Study (ARCOS IV) 2011-2012. Int J Stroke (2013) 0.80

Family history of stroke: an old and still unproven risk factor. Hypertens Res (2008) 0.77

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18

Role of genotype in the cycle of violence in maltreated children. Science (2002) 13.50

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med (2006) 12.90

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet (2008) 12.32

Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet (2012) 10.30

Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06

Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol (2008) 9.02

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Incidental findings on brain MRI in the general population. N Engl J Med (2007) 8.59

A gradient of childhood self-control predicts health, wealth, and public safety. Proc Natl Acad Sci U S A (2011) 8.57

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation (2006) 8.18

Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA (2005) 8.07

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis (2008) 7.45

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med (2006) 7.32

Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30

Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry (2003) 7.28

Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet (2015) 7.16

A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med (2003) 7.03

Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med (2004) 6.77

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49

Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation (2003) 6.47

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

The evolving diabetes burden in the United States. Ann Intern Med (2004) 6.36

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J (2006) 6.31

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13